The China biologics market is poised for substantial growth, with forecasts indicating a remarkable surge in market size from USD 39.76 billion in 2023 to USD 278.42 billion by 2035. This represents an impressive compound annual growth rate (CAGR) of 17.73% over the forecast period. With increasing demand for personalized medicine and advancements in biotechnology, the momentum within this...